Improving outcomes of pregnancy for women with type 1 and type 2 diabetes

British Journal of Diabetes and Vascular Disease

Volumn 7, Issue 1, 2007, Pages 38-42

  Murphy, Helen R ^a   Temple, Rosemary C ^b   Roland, Jonathan M ^c  

^a IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c PETERBOROUGH CITY HOSPITAL   (United Kingdom)

Author keywords

Pregnancy; Prepregnancy care; Type 1 diabetes; Type 2 diabetes

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; METHYLDOPA; NIFEDIPINE; ORAL ANTIDIABETIC AGENT; VALPROIC ACID;

ARTICLE; CLINICAL TRIAL; CONGENITAL MALFORMATION; DIABETES CONTROL; DIABETIC DIET; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; ETHNIC GROUP; FEMALE; FETOTOXICITY; HEALTH CARE NEED; HEALTH CARE PERSONNEL; HIGH RISK PREGNANCY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MATERNAL CARE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PERINATAL MORTALITY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL CARE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION; SOCIAL ISOLATION; STILLBIRTH; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNPLANNED PREGNANCY;

EID: 33947261124     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/14746514070070010701     Document Type: Article

References (45)

1. Confidential Enquiry into Maternal and Child Health. Pregnancy in women with type 1 and type 2 diabetes in 2002-03, England, Wales and Northern Ireland. London: CEMACH; 2005.
2. Macintosh MC, Fleming KM, Bailey A et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 2006;333:177.
3. Miller E, Hare JW, Cloherty JP et at. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 198 1;304:1331-4.
4. Ylinen K, Aula F, Stenman UH, Kesaniemi-Kuokkanen T, Teramo K. Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy Br Med J (Clin Res Ed) 1984;289:345-6.
5. Clausen TD, Mathiesen E, Ekbom P, Hellmuth E, Mandrup-Poulsen T, Damm P. Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 2005;28:323-8.
6. McElduff A, Ross GP, Lagstrom JA et al. Pregestational diabetes and pregnancy: an Australian experience. Diabetes Care 2005;28:1260-1.
7. Dunne F, Brydon P, Smith K, Gee H. Pregnancy in women with type 2 diabetes: 12 years outcome data 1990-2002. Diabet Med 2003;20:734-8.
8. Roland JM, Murphy HR, Ball V, Northcote-Wright J, Temple RC. The pregnancies of women with type 2 diabetes: poor outcomes but opportunities for improvement. Diabet Med 2005;22:1774-7.
9. Mills JL, Knopp RH, Simpson JL et al. Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 1988;318:671-6.
10. Fuhrmann K, Reiher H, Semmler K, Fischer F, Fischer M, Glockner E. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care 1983;6:219-23.
11. Fuhrmann K, Reiher H, Semmler K, Glockner E. The effect of intensified conventional insulin therapy before and during pregnancy on the malformation rate in offspring of diabetic mothers. Exp Clin Endocrinol 1984;83:173-7.
12. Jensen BM, Kuhl C, Molsted-Pedersen L, Saurbrey N, Fog-Pedersen J. Preconceptional treatment with insulin infusion pumps in insulin-dependent diabetic women with particular reference to prevention of congenital malformations. Acta Endocrinol Suppl (Copenh) 1986;277:81-5.
13. Goldman JA, Dicker D, Feldberg D, Yeshaya A, Samuel N, Karp M. Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconceptional diabetic control: a comparative study. Am J Obstet Gynecol 1986,155:293-7.
14. Rowe BR, Rowbotham CJ, Barnett AH. Pre-conception counselling, birth weight, and congenital abnormalities in established and gestational diabetic pregnancy. Diabetes Res 1987;6(1):33-5.
15. Damm P, Molsted-Pedersen L. Significant decrease in congenital malformations in newborn infants of an unselected population of diabetic women. Am J Obstet Gynecol 1989;161:1163-7.
16. Steel JM, Johnstone FD, Hepburn DA, Smith AF. Can prepregnancy care of diabetic women reduce the risk of abnormal babies? BMJ 1990;301:1070-4.
17. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD. Preconception care of diabetes. Glycemic control prevents congenital anomalies. Jama 1991;265:731-6.
18. Willhoite MB, Bennert HW, Jr., Palomaki GE et al. The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program. Diabetes Care 1993;16:450-5.
19. Cousins L, Kitzmiller J, Schneider J et al. The California Diabetes and Pregnancy Program: implementation of a multicenter experience with diabetic pregnancies. J Perinatol 1992;12:173-80.
20. Temple RC, Aldridge V, Murphy HR. Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care 2006;29:1744-9.
21. Temple R, Aldridge V, Greenwood R, Heyburn P, Sampson M, Stanley K. Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study. BMJ 2002;325:1275-6.
22. Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM 2001;94:435-44.
23. Gregory R, Tattersall RB. Are diabetic pre-pregnancy clinics worth while? Lancet 1992;340:656-8.
24. Holing EV, Beyer CS, Brown ZA, Connell FA. Why don't women with diabetes plan their pregnancies? Diabetes Care 1998,21:889-95.
25. Janz NK, Herman WH, Becker MP et al. Diabetes and pregnancy. Factors associated with seeking pre-conception care. Diabetes Care 1995;18: 157-65.
26. Roland JM, Murphy HR, Ball V, Northcote-Wright T, Temple RC. Type 2 diabetic pregnancies have a much worse outcome than type 1 pregnancies but with opportunities for improvement. Diabet Med 2005;In press.
27. Dunstan DW, Zimmet PZ, Welborn TA et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002;25:829-34.
28. Cundy T, Gamble G, Townend K, Henley PG, MacPherson P, Roberts AB. Perinatal mortality in type 2 diabetes mellitus. Diabet Med 2000;17(1): 33-9.
29. Dunne F. Type 2 diabetes and pregnancy. Semin Fetal Neonatal Med 2005;10:333-9.
30. Farrell T, Neale L, Cundy T. Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet Med 2002, 19:322-6.
31. Cundy T, Slee F, Gamble G, Neale L. Hypertensive disorders of pregnancy in women with type 1 and type 2 diabetes. Diabet Med 2002;19:482-9.
32. Coetzee EJ, Jackson WP. Oral hypoglycaemics in the first trimester and fetal outcome. S Afr Med 11984;65:635-7.
33. Hellmuth E, Damm P, Molsted-Pedersen L. Congenital malformations in offspring of diabetic women treated with oral hypoglycaemic agents during embryogenesis. Diabet Med 1994;11:471-4.
34. Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002;17:2858-64.
35. Piacquadio K, Hollingsworth DR, Murphy H. Effects of in-utero exposure to oral hypoglycaemic drugs. Lancet 1991;338:866-9.
36. Hughes RC, Rowan JA. Pregnancy in women with type 2 diabetes: who takes metformin and what is the outcome? Diabet Med 2006;23:318-22.
37. Hawthorne G. Metformin use and diabetic pregnancy-has its time come? Diabet Med 2006;23:223-7.
38. Simmons D, Walters BN, Rowan JA, McIntyre HD. Metformin therapy and diabetes in pregnancy. Med J Aust 2004;180:462-4.
39. Glueck CJ, Goldenberg N, Wang P, Loftspring M, Sherman A. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod 2004;19:510-21.
40. National Centre for Health Statistics. National Health Care Survey. In: www.cdcgoc/nchs/nhcshtm; 2006.
41. Friedman JM. ACE inhibitors and congenital anomalies. N Engl J Med 2006;354:2498-500.
42. Cooper WO, Hernandez-Diaz S, Arbogast PG et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006;354:2443-51.
43. Friedman J, Polifka J. Teratogenic effects of drugs: a resource for clinicians (TERIS). Baltimore: Johns Hopkins University Press 2000.
44. Statins: beware during pregnancy. Prescrire Int 2006;15(81):18-19.
45. Kenis I, Tartakover-Matalon S, Cherepnin N et al. Simvastatin has deleterious effects on human first trimester placental explants. Hum Reprod 2005;20:2866-72.